Point-of-Care Diagnostics Market Forecast Highlights Growing Adoption of Rapid and Portable Diagnostic Devices
The global point-of-care diagnostics market is witnessing significant growth as healthcare providers increasingly prioritize early disease detection, rapid testing, and decentralized healthcare delivery. Point-of-care (PoC) diagnostics enable medical professionals to conduct diagnostic tests near patients and obtain results within a shorter timeframe compared with conventional laboratory-based testing. Growing demand for accessible healthcare, rising prevalence of chronic and infectious diseases, and technological advancements in portable diagnostic devices are creating new growth opportunities for the industry.
According to the industry analysis, the global point-of-care diagnostics market was valued at USD 19.1 billion in 2025 and is projected to reach USD 43.7 billion by 2036, expanding at a CAGR of 7.8% from 2026 to 2036. Increasing adoption of home-based testing, improvements in diagnostic accuracy, and integration of digital health technologies are expected to support market expansion.
https://www.transparencymarketresearch.com/care-diagnostics-market.html
Point-of-Care Diagnostics Market: Rising Demand for Rapid and Early Disease Detection
The increasing prevalence of chronic and infectious diseases is one of the primary factors driving the global point-of-care diagnostics market. Conditions such as diabetes, cardiovascular diseases, respiratory infections, and other chronic disorders require timely diagnosis and continuous monitoring. Point-of-care testing allows healthcare professionals to obtain diagnostic information quickly, supporting faster treatment decisions and improved patient management.
Hospitals, emergency departments, clinics, and ambulatory care centers are increasingly adopting rapid diagnostic solutions to reduce waiting times and improve operational efficiency. These technologies are particularly valuable in emergency and critical care settings, where immediate test results can influence clinical decisions.
The growing burden of infectious diseases is also increasing demand for rapid testing products. Diagnostic solutions for influenza, HIV, sexually transmitted infections, and healthcare-associated infections are becoming important components of modern healthcare systems. The availability of portable testing devices is improving access to diagnostics in locations with limited laboratory infrastructure.
Home-Based Testing and Remote Patient Monitoring Create New Opportunities
The increasing preference for home-based healthcare is creating significant opportunities for point-of-care diagnostic manufacturers. Patients are increasingly adopting self-testing solutions to monitor glucose levels, cholesterol, pregnancy status, and selected infectious diseases without frequent hospital visits.
Home-based testing provides convenience, supports patient participation in healthcare management, and can reduce pressure on healthcare facilities. The expansion of digital pharmacies and e-commerce platforms is also improving the availability of over-the-counter diagnostic products.
Remote patient monitoring is further strengthening market demand. Connected glucose monitors and other portable diagnostic devices enable patients to share health information with healthcare professionals through digital platforms. This supports ongoing disease management and allows medical professionals to monitor patient conditions outside conventional healthcare facilities.
The growing integration of telemedicine and connected healthcare services is expected to create additional opportunities for manufacturers offering digitally enabled diagnostic products.
Technological Advancements Transform Point-of-Care Testing
Technological innovation is playing an important role in improving the performance and accessibility of point-of-care diagnostic systems. Developments in biosensors, microfluidics, immunoassays, and molecular diagnostics are enabling manufacturers to introduce compact devices with improved sensitivity and faster turnaround times.
Molecular diagnostic technologies, including polymerase chain reaction (PCR) and isothermal nucleic acid amplification technology (INAAT), are gaining attention for their ability to identify infectious diseases through the detection of specific genetic material.
Immunoassay-based systems are widely used for detecting biomarkers, hormones, infectious diseases, and other clinical indicators. Biochemistry-based diagnostic devices are also important for glucose monitoring and cardiometabolic testing.
Artificial intelligence and smartphone connectivity are creating additional opportunities. AI-powered software can support automated result interpretation, diagnostic workflows, and clinical decision-making. Smartphone-connected testing platforms can improve data sharing between patients and healthcare providers, particularly in remote and underserved communities.
OTC Products Segment Dominates Purchasing Demand
Based on mode of purchase, the point-of-care diagnostics market is categorized into prescription-based products and over-the-counter (OTC) products.
The OTC products segment accounted for the largest market share of 62.5% in 2025. Its leading position reflects increasing consumer preference for convenient self-testing and accessible healthcare solutions.
Home pregnancy tests, glucose monitoring products, cholesterol testing kits, and selected infectious disease tests are contributing to demand for OTC diagnostic solutions. Improvements in product accuracy, ease of use, and availability through online distribution channels are further strengthening this segment.
The growing focus on preventive healthcare is encouraging consumers to monitor their health conditions more frequently. Manufacturers are responding by developing user-friendly diagnostic products that provide reliable results and support better health awareness.
As healthcare systems increasingly adopt patient-centric models, OTC point-of-care testing is expected to remain an important source of market growth.
Product Innovation Expands Applications Across Healthcare
Based on product, the global point-of-care diagnostics market includes infectious disease testing products, glucose monitoring products, cardiometabolic monitoring products, pregnancy and fertility testing products, coagulation monitoring products, tumor and cancer marker testing products, urinalysis testing products, cholesterol testing products, hematology testing products, and others.
Infectious disease testing products represent an important category because of the need for rapid identification of communicable diseases. Products designed for influenza, HIV, sexually transmitted diseases, and healthcare-associated infections are supporting decentralized testing.
Glucose monitoring products are benefiting from the increasing prevalence of diabetes and the growing need for continuous disease management. Cardiometabolic monitoring products are also gaining importance as healthcare providers focus on identifying cardiovascular risk factors at an early stage.
Pregnancy and fertility testing products continue to benefit from the availability of convenient home-based solutions. Meanwhile, coagulation monitoring, tumor marker testing, urinalysis, and hematology products are expanding the clinical applications of point-of-care technologies.
North America Leads the Global Point-of-Care Diagnostics Market
North America dominated the global point-of-care diagnostics market in 2025, accounting for 42.3% of total revenue. The region benefits from advanced healthcare infrastructure, high awareness of preventive healthcare, favorable reimbursement conditions for several diagnostic procedures, and strong adoption of innovative medical technologies.
The United States represents a major contributor due to the presence of established diagnostic manufacturers, hospitals, research institutions, and healthcare technology companies. Increasing demand for diabetes monitoring, infectious disease testing, and home-based diagnostics is supporting regional growth.
Canada is also contributing through investments in healthcare accessibility, diagnostic infrastructure, and digital health services.
Europe represents another important market, supported by established healthcare systems and increasing demand for rapid diagnostic technologies. Asia Pacific offers significant growth opportunities due to expanding healthcare infrastructure, rising healthcare expenditure, and increasing awareness of early disease detection in countries such as China, India, and Japan.
Latin America and the Middle East & Africa are also emerging markets as governments and healthcare providers invest in accessible diagnostic services.
Competitive Landscape and Key Market Participants
The global point-of-care diagnostics market is characterized by technological innovation, product portfolio expansion, strategic partnerships, and investments in research and development.
Major companies operating in the market include Abbott, BD, Bio-Rad Laboratories, Inc., bioMérieux SA, Cardinal Health Inc., Danaher Corporation, EKF Diagnostics Holdings plc, F. Hoffmann-La Roche AG, Johnson & Johnson Services, Inc., Nova Biomedical, Quidel Corporation, Siemens Healthcare GmbH, Thermo Fisher Scientific, Inc., and Trinity Biotech Plc.
These companies are focusing on developing rapid testing technologies, improving diagnostic accuracy, expanding home-testing portfolios, and strengthening distribution networks.
Recent product developments highlight the industry's innovation-driven growth. In May 2025, SEKISUI Diagnostics announced the launch of a rapid diagnostic testing tool for detecting respiratory syncytial virus (RSV) in professional healthcare settings.
In March 2025, Visby Medical received U.S. FDA De Novo authorization for its Women's Sexual Health Test for over-the-counter use, enabling at-home testing for chlamydia, gonorrhea, and trichomoniasis.
In April 2025, DexCom announced FDA clearance of its Dexcom G7 15 Day Continuous Glucose Monitoring System for adults with diabetes in the United States. These developments demonstrate the increasing focus on convenient, rapid, and patient-centered diagnostic technologies.
Market Challenges and Emerging Business Opportunities
Despite strong growth prospects, the point-of-care diagnostics industry faces challenges related to the high cost of advanced diagnostic systems, reimbursement limitations, regulatory requirements, and concerns regarding test reliability compared with conventional laboratory methods.
Maintaining consistent diagnostic accuracy across different testing environments is essential for manufacturers. Companies must also invest in quality control, clinical validation, and user training to strengthen confidence among healthcare professionals and consumers.
However, emerging economies offer substantial opportunities through healthcare infrastructure development and increasing demand for accessible diagnostic services. Integration of artificial intelligence, smartphone applications, connected devices, and digital health platforms is expected to create new revenue opportunities.
Future Outlook of the Point-of-Care Diagnostics Market
The global point-of-care diagnostics market is expected to maintain strong growth through 2036 as healthcare systems increasingly shift toward decentralized, preventive, and patient-focused care. Rising chronic disease prevalence, growing infectious disease testing requirements, and increasing adoption of home-based diagnostics will remain important growth drivers.
Advancements in molecular diagnostics, immunoassays, biosensors, and AI-enabled testing platforms are expected to improve diagnostic capabilities and expand clinical applications. OTC products, connected glucose monitoring systems, and portable infectious disease testing solutions will provide attractive opportunities for manufacturers.
Companies investing in product innovation, digital integration, regulatory compliance, and emerging market expansion are likely to strengthen their competitive positions.
- Art
- Causes
- Crafts
- Dance
- Drinks
- Film
- Fitness
- Food
- Игры
- Gardening
- Health
- Главная
- Literature
- Music
- Networking
- Другое
- Party
- Religion
- Shopping
- Sports
- Theater
- Wellness